No abstract

Transient receptor potential canonical type 6 (TRPC6) is a nonselective receptor-operated cation channel that regulates reactive fibrosis and growth signaling. Increased TRPC6 activity from enhanced gene expression or gain-of-function mutations contribute to cardiac and/or renal disease. Despite evidence supporting a pathophysiological role, no orally bioavailable selective TRPC6 inhibitor has yet been developed and tested in vivo in disease models. Here, we report an orally bioavailable TRPC6 antagonist (BI 749327; IC 50 13 nM against mouse TRPC6, t 1/2 8.5-13.5 hours) with 85-and 42-fold selectivity over the most closely related channels, TRPC3 and TRPC7. TRPC6 calcium conductance results in the stimulation of nuclear factor of activated T cells (NFAT) that triggers pathological cardiac and renal fibrosis and disease. BI 749327 suppresses NFAT activation in HEK293T cells expressing wild-type or gain-of-function TRPC6 mutants (P112Q, M132T, R175Q, R895C, and R895L) and blocks associated signaling and expression of prohypertrophic genes in isolated myocytes. In vivo, BI 749327 (30 mg/kg/day, yielding unbound trough plasma concentration ∼180 nM) improves left heart function, reduces volume/mass ratio, and blunts expression of profibrotic genes and interstitial fibrosis in mice subjected to sustained pressure overload. Additionally, BI 749327 dose dependently reduces renal fibrosis and associated gene expression in mice with unilateral ureteral obstruction. These results provide in vivo evidence of therapeutic efficacy for a selective pharmacological TRPC6 inhibitor with oral bioavailability and suitable pharmacokinetics to ameliorate cardiac and renal stress-induced disease with fibrosis. TRPC6 | ion channels | calcium | nuclear factor of activated T cells | fibrosis

Abstract

No abstract

No abstract

No abstract

No abstract

The electronic structures and optoelectronic properties of several blue-emitting phosphors (dfppy)(2)Ir(pyN2), (dfppy)Ir(pyN2)(2), and (fpmb)(2)Ir(pyN3) [dfppyH: 2-(2,4-difluorophenyl)pyridine; pyN2H: 5-(2-pyridyl)-3-trifluoromethylpyrazole; Hfpmb: 1-(4-fluorophenyl)-2,3-dihydro-3-methyl-1H-benzo[d]imidazole; and pyN3H: 2-(5-(trifluoromethyl)-2H-1,2,4-triazol-3-yl)pyridine] are investigated with density functional theory. The injection abilities of holes and electrons are estimated by evaluating the ionization potentials and electron affinities. It is found that the properties of the ligands have great influence on the photophysical properties, such as energy gap, absorption spectra, emission spectra, etc. The assumed complex (dfppy)(2)Ir(pyN2) is found to be a good candidate for blue-emitting material. We suggest that the luminescent properties of this class of materials can be tuned by modifications of the corresponding ligands.